Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Down syndrome and personalized medicine: changing paradigms from genotype to phenotype to treatment.

McCabe LL, McCabe ER.

Congenit Anom (Kyoto). 2013 Mar;53(1):1-2. doi: 10.1111/cga.12000. Review.

PMID:
23480351
2.

Personalized medicine for individuals with Down syndrome.

McCabe LL, McCabe ER.

Mol Genet Metab. 2011 Sep-Oct;104(1-2):7-9. doi: 10.1016/j.ymgme.2011.07.008. Epub 2011 Jul 19. Review.

PMID:
21807541
3.

Information management to enable personalized medicine: stakeholder roles in building clinical decision support.

Downing GJ, Boyle SN, Brinner KM, Osheroff JA.

BMC Med Inform Decis Mak. 2009 Oct 8;9:44. doi: 10.1186/1472-6947-9-44.

4.

Genomic and personalized medicine: foundations and applications.

Ginsburg GS, Willard HF.

Transl Res. 2009 Dec;154(6):277-87. doi: 10.1016/j.trsl.2009.09.005. Epub 2009 Oct 1. Review.

PMID:
19931193
5.

Personalized oncology: recent advances and future challenges.

Kalia M.

Metabolism. 2013 Jan;62 Suppl 1:S11-4. doi: 10.1016/j.metabol.2012.08.016. Epub 2012 Sep 19. Review.

PMID:
22999010
6.

Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.

Roukos DH.

Expert Rev Mol Diagn. 2010 Jan;10(1):33-48. doi: 10.1586/erm.09.69. Review.

PMID:
20014921
7.

Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach.

Zhang A, Sun H, Wang P, Han Y, Wang X.

Complement Ther Med. 2012 Feb-Apr;20(1-2):93-9. doi: 10.1016/j.ctim.2011.10.007. Epub 2011 Nov 30.

PMID:
22305254
8.

Down syndrome and Alzheimer's disease: children grow older.

Waldman HB, Perlman SP, Roesch RE.

Gen Dent. 2008 Jul-Aug;56(5):420-2.

PMID:
18683397
9.

Amyloid beta concentrations in older people with Down syndrome and dementia.

Jones EL, Hanney M, Francis PT, Ballard CG.

Neurosci Lett. 2009 Feb 20;451(2):162-4. doi: 10.1016/j.neulet.2008.12.030. Epub 2008 Dec 24.

PMID:
19111900
10.

Down syndrome and beta-amyloid deposition.

Head E, Lott IT.

Curr Opin Neurol. 2004 Apr;17(2):95-100. Review.

PMID:
15021233
11.

The 50th anniversary of the discovery of trisomy 21: the past, present, and future of research and treatment of Down syndrome.

Mégarbané A, Ravel A, Mircher C, Sturtz F, Grattau Y, Rethoré MO, Delabar JM, Mobley WC.

Genet Med. 2009 Sep;11(9):611-6. doi: 10.1097/GIM.0b013e3181b2e34c. Review.

PMID:
19636252
12.

[Potential benefits and limitations of new technologies in the personalized treatment of depression].

Carlino D, De Vanna M.

Riv Psichiatr. 2011 May-Jun;46(3):155-71. doi: 10.1708/889.9806. Review. Italian.

PMID:
21779096
13.

Molecular diagnostics and personalized medicine in oncology: challenges and opportunities.

Normanno N, Rachiglio AM, Roma C, Fenizia F, Esposito C, Pasquale R, La Porta ML, Iannaccone A, Micheli F, Santangelo M, Bergantino F, Costantini S, De Luca A.

J Cell Biochem. 2013 Mar;114(3):514-24. doi: 10.1002/jcb.24401.

PMID:
22991232
14.

Apo E genotypes and risk of dementia in Down syndrome.

Rubinsztein DC, Hon J, Stevens F, Pyrah I, Tysoe C, Huppert FA, Easton DF, Holland AJ.

Am J Med Genet. 1999 Aug 20;88(4):344-7.

PMID:
10402500
15.

Translational bioinformatics and systems biology approaches for personalized medicine.

Yan Q.

Methods Mol Biol. 2010;662:167-78. doi: 10.1007/978-1-60761-800-3_8.

PMID:
20824471
16.

Genetic studies in chronic kidney disease: interpretation and clinical applicability.

Witasp A, Nordfors L, Carrero JJ, Luttropp K, Lindholm B, Schalling M, Stenvinkel P.

J Nephrol. 2012 Nov-Dec;25(6):851-64. doi: 10.5301/jn.5000216. Review.

PMID:
23042432
17.

Personalized medicine using DNA biomarkers: a review.

Ziegler A, Koch A, Krockenberger K, Grosshennig A.

Hum Genet. 2012 Oct;131(10):1627-38. doi: 10.1007/s00439-012-1188-9. Epub 2012 Jul 1. Review.

18.

Personalized medicine in women's obesity prevention and treatment: implications for research, policy and practice.

Yang N, Ginsburg GS, Simmons LA.

Obes Rev. 2013 Feb;14(2):145-61. doi: 10.1111/j.1467-789X.2012.01048.x. Epub 2012 Oct 31. Review.

PMID:
23114034
19.

Bioinformatics linkage of heterogeneous clinical and genomic information in support of personalized medicine.

Frey LJ, Maojo V, Mitchell JA.

Yearb Med Inform. 2007:98-105. Erratum in: Yearb Med Inform. 2008:19.

PMID:
17700912
20.

Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.

Fredolini C, Liotta LA, Petricoin EF.

Crit Rev Clin Lab Sci. 2010 May-Jun;47(3):125-38. doi: 10.3109/10408363.2010.503558. Epub 2010 Sep 21. Review.

PMID:
20858067

Supplemental Content

Support Center